Unexplained weight loss is one of depression’s least-discussed symptoms — yet research shows that nearly half of adults with major depressive disorder experience significant appetite decreases, and roughly a third lose measurable weight during a depressive episode (Simmons et al., 2016). If you or someone you love has been losing weight without trying and can’t explain why, depression may be part of the picture. Understanding the connection between mood and appetite is the first step toward getting the right kind of help.
Why Depression Affects Your Weight
Most people associate depression with persistent sadness or a loss of interest in activities they once enjoyed. Those are real and defining symptoms, but depression treatment in South Chesterfield recognizes depression as a physical illness with measurable effects on the body — and appetite disruption is one of them. The DSM-5, the diagnostic manual used by mental health clinicians, includes significant weight loss (defined as losing more than 5% of body weight in a month) or a noticeable decrease in appetite as a diagnostic criterion for major depressive disorder (MDD).
What drives this connection is neurobiological, not simply a matter of forgetting to eat. Research published in the American Journal of Psychiatry found that depressed individuals who lose appetite show distinct patterns of disrupted activity in the brain’s interoceptive cortex — the region that processes internal body signals like hunger — compared both to healthy individuals and to depressed individuals who overeat (Simmons et al., 2016). Depression, in other words, can interfere with the brain’s ability to register and respond to hunger cues at a fundamental level.
This neurological disruption is compounded by other depression symptoms that reduce food intake indirectly. When depression causes fatigue so severe that preparing a meal feels impossible, or when anhedonia — the clinical term for the loss of pleasure in previously enjoyable activities — extends to food itself, eating becomes something that simply doesn’t happen. Psychomotor agitation, which can include restless movement and an inability to sit still, burns additional calories on top of the reduced intake. The result is a pattern of unintentional weight loss that, if left unaddressed, can compound the physical toll of depression significantly.
The Two Faces of Depression and Appetite
One reason this symptom is often missed is that depression doesn’t always cause weight loss. For many people, depression drives the opposite pattern — increased appetite, cravings for carbohydrate-rich foods, and weight gain. Both patterns are real and both are clinically recognized. Our blog post on depression and weight loss explores this topic further.
Research from the International Journal of Molecular Sciences clarifies that the direction of appetite change in depression is tied to depressive subtype. The melancholic form of MDD is specifically associated with decreased appetite and weight loss, while the atypical form is associated with increased appetite and weight gain (Sáez-Francàs et al., 2024). Perhaps most importantly, the same study found that an individual’s pattern of appetite change tends to remain consistent across approximately 80% of depressive episodes over time — meaning that if you tend to lose weight when depressed, that pattern is likely to repeat.
A further study in Molecular Psychiatry found that the two appetite subtypes of depression are not just behaviorally different — they reflect distinct endocrine, metabolic, and inflammatory states in the body (Simmons et al., 2018). Individuals experiencing appetite loss show different cortisol and inflammatory profiles than those experiencing appetite increase. This distinction matters clinically because it may influence which treatment approaches are most appropriate for a given patient.
When Unexplained Weight Loss Warrants Evaluation
Unexplained weight loss should always prompt a conversation with a healthcare provider, because many medical conditions — thyroid disorders, gastrointestinal disease, diabetes, and others — can also cause unintentional weight loss. Ruling out those causes is an important part of the picture. But if your medical workup comes back unremarkable and you have also been experiencing persistent low mood, loss of interest in things that used to bring you joy, disrupted sleep, fatigue, difficulty concentrating, or feelings of hopelessness, depression deserves serious consideration as a contributing factor.
The overlap between physical and emotional symptoms is one reason depression is frequently underdiagnosed. People see their primary care provider about weight loss and have labs ordered; they don’t always mention that they haven’t felt like themselves emotionally in months. We encourage anyone in the Richmond area experiencing this combination of symptoms to tell the whole story — both the physical and the emotional — to whoever is helping them investigate. Our post on the signs and symptoms of high-functioning depression can help you recognize patterns that are easy to overlook.
What Treatment-Resistant Depression Means, and What Comes Next
Many people struggling with depression have already tried one or more antidepressant medications by the time they seek additional help. When a person has not responded adequately to at least two antidepressant trials at therapeutic doses, clinicians use the term treatment-resistant depression (TRD). This designation is not a verdict — it is a clinical signal that the underlying biology of their depression may involve pathways that standard medications don’t directly target.
At InfuseRVA Ketamine & Wellness, we work specifically with patients who haven’t found adequate relief through conventional treatment. Our team evaluates each patient individually before recommending any treatment approach. For patients who meet criteria for TRD, IV ketamine infusion therapy — which works through the glutamate system rather than the serotonin pathways targeted by most antidepressants — may offer a different avenue worth exploring. We also offer SPRAVATO® (esketamine) treatment, an FDA-approved option for treatment-resistant depression and major depressive disorder with acute suicidal ideation or behavior, which is administered in our supervised clinical setting.
We want to be clear about what these treatments are and aren’t. Results vary by individual, and neither ketamine infusion therapy nor SPRAVATO® is appropriate for everyone. Every patient who comes to us for ketamine-related treatment is evaluated by our medical director or a licensed physician before treatment begins. We review prior diagnoses, past treatment history, current medications, and any adverse reactions as part of that process. Our goal is to give each person the most informed, personalized path forward that we can.
Addressing the Barriers That Prevent People From Getting Help
Cost is a real concern for many patients considering ketamine-based treatments. IV ketamine infusion therapy is not covered by insurance, as it is currently considered off-label for depression. We accept cash and credit cards, and we encourage patients to explore whether their HSA or FSA funds may be applicable. SPRAVATO®, because it carries FDA approval for TRD and MDD with acute suicidal ideation, has a different insurance profile — coverage varies by plan, and our team can help clarify what applies to your situation.
We also hear from patients who hesitate because they aren’t sure depression is really what’s happening to them, or because they’ve been managing on their own for so long that seeking specialized help feels like an admission of defeat. It isn’t. Depression that changes how your body functions — your appetite, your weight, your ability to do the things that make up a life — is a medical condition that deserves medical attention. You don’t have to have a formal diagnosis in hand before reaching out. That’s what the evaluation process is for. If you have questions about what to expect, our ketamine infusion FAQs are a helpful starting point.
Frequently Asked Questions
Can depression really cause significant weight loss? Yes — appetite disruption is one of the nine DSM-5 diagnostic criteria for major depressive disorder. Research consistently shows that roughly 30–48% of adults with MDD experience decreased appetite and measurable weight loss during depressive episodes (Simmons et al., 2016). The mechanism is neurobiological and involves disrupted activity in the brain regions that regulate hunger signals.
How do I know if my weight loss is from depression or something else? You can’t determine this on your own, and that’s why a full medical evaluation matters. Unexplained weight loss should first be assessed by a primary care provider to rule out thyroid dysfunction, gastrointestinal conditions, diabetes, and other physical causes. If no physical explanation emerges and you are also experiencing emotional symptoms — persistent low mood, loss of interest, fatigue, sleep changes, difficulty concentrating — depression should be part of the conversation with your provider.
What if antidepressants haven’t worked for me? Not responding to one or more antidepressants doesn’t mean depression is untreatable. When two or more medication trials at adequate doses haven’t produced sufficient relief, that pattern meets the clinical definition of treatment-resistant depression — and there are evidence-based options beyond standard antidepressants worth exploring. We encourage you to discuss those options with your current provider and to reach out to us if you’d like to learn more about what we offer in the Richmond area.
Does treating depression help with the weight loss? Often, yes. Addressing the underlying depression tends to restore appetite regulation over time, though the timeline and degree of improvement vary by individual. If significant weight loss has occurred, working with both a mental health provider and a primary care provider to restore nutritional status alongside treating depression is generally the most comprehensive approach.
Is ketamine therapy right for me if I have depression and weight loss? That depends on your full clinical picture, which is why we conduct a thorough evaluation before recommending any treatment. IV ketamine infusion therapy and SPRAVATO® are options that may be appropriate for patients with treatment-resistant depression who have not found adequate relief through conventional means. The only way to know whether you’re a candidate is through a proper evaluation. We’re here to have that conversation.
Key Takeaways
- Unexplained weight loss is a recognized and neurobiologically grounded symptom of major depressive disorder, affecting approximately 30–48% of adults with MDD.
- Depression-related weight loss is tied to the melancholic subtype of MDD and reflects disrupted brain activity in hunger-regulating regions, not simply reduced motivation to eat.
- An individual’s pattern of appetite change in depression — loss or gain — tends to remain consistent across depressive episodes, making it a meaningful clinical marker.
- When standard antidepressants haven’t provided adequate relief, treatment-resistant depression protocols including IV ketamine infusion therapy and SPRAVATO® may offer additional options worth discussing with a qualified provider.
- Results vary by individual, and all treatment decisions should be made through a thorough medical evaluation in partnership with your care team.
The weight loss you’ve noticed may be your body communicating what words haven’t fully captured yet. At InfuseRVA Ketamine & Wellness, we take both the physical and emotional dimensions of depression seriously, and our team is ready to help you understand your options. If you’re in the Richmond, South Chesterfield, or greater RVA area and are ready to take the first step, call us at804-895-4636 or schedule a consultation with our team today. You deserve answers — and a path forward.
References
Sáez-Francàs, N., Alegre-Martín, J., & Calvo, N. (2024). Mechanisms involved in the link between depression, antidepressant treatment, and associated weight change. International Journal of Molecular Sciences, 25(8), 4511. https://pmc.ncbi.nlm.nih.gov/articles/PMC11050075/
Simmons, W. K., et al. (2016). Depression-related increases and decreases in appetite reveal dissociable patterns of aberrant activity in reward and interoceptive neurocircuitry. American Journal of Psychiatry, 173(4), 418–428. https://pmc.ncbi.nlm.nih.gov/articles/PMC4818200/
Simmons, W. K., et al. (2018). Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states. Molecular Psychiatry, 25(7), 1457–1468. https://pmc.ncbi.nlm.nih.gov/articles/PMC6292746/
Medical Disclaimer
The information in this blog is intended for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Unexplained weight loss and depression symptoms should be evaluated by a licensed healthcare provider familiar with your full medical and psychiatric history. Individual results vary. Treatment with IV ketamine infusion therapy or SPRAVATO® should only be pursued under the supervision of qualified medical professionals after a thorough evaluation. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline, or go to your nearest emergency room.
